NCT02968576View on ClinicalTrials.gov

Bioequivalence of Tenofovir and Emtricitabine Following Overencapsulation

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

June 30, 2017

Conditions
Healthy VolunteersPharmacokinetics
Interventions
DRUG

TENOFOVIR DISOPROXIL FUMARATE 300 Mg / EMTRICITABINE 200 Mg ORAL TABLET [TRUVADA]

DEVICE

Proteus Sensor System

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02968576 - Bioequivalence of Tenofovir and Emtricitabine Following Overencapsulation | Biotech Hunter | Biotech Hunter